Back to News
Market Impact: 0.6

Verisk Analytics stock rating reiterated at Outperform by RBC Capital

VRSK
Company FundamentalsAnalyst InsightsCorporate EarningsCorporate Guidance & OutlookTechnology & InnovationArtificial IntelligenceNatural Disasters & WeatherProduct Launches
Verisk Analytics stock rating reiterated at Outperform by RBC Capital

RBC Capital reiterated an Outperform rating on Verisk Analytics (VRSK) with a $314 price target, projecting a modest 7.3% organic growth beat for FY25, though the company is expected to maintain its full-year guidance due to potential impacts from a below-average hurricane season on its P&C insurance segment. Despite trading near its 52-week low and some overvaluation concerns, Verisk recently surpassed Q2 2025 earnings and revenue estimates and launched new AI-powered tools, reinforcing its market position in data analytics.

Analysis

Verisk Analytics (VRSK) has received a reiterated 'Outperform' rating from RBC Capital with a $314 price target, indicating substantial upside from its current price of $246.83, which is near its 52-week low of $239.83. This bullish sentiment is supported by a recent Q2 2025 earnings beat, where EPS reached $1.88 against a $1.77 forecast, and by Wolfe Research initiating coverage with a similar 'Outperform' rating. The company's fundamentals appear robust, with last-twelve-months revenue growth of 7.6% and impressive gross profit margins of 69.39%. However, there are moderating factors to consider. RBC anticipates Verisk will maintain its FY25 organic growth guidance despite a projected 7.3% organic growth beat, primarily due to the potential for a below-average hurricane season, which could negatively impact its catastrophe modeling business. Furthermore, a conflicting signal from InvestingPro suggests the company may be overvalued at current levels. Key strategic developments include the launch of the XactAI suite to enhance claims processing efficiency and the inclusion of a $40-50 million contribution from acquisitions in its FY25 guidance, making the closing of the AccuLynx deal a critical event to monitor.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo